BMS, J&J, Bayer lead 25,000+ pharma layoffs in 2024; Amylyx, FibroGen, Kronos Bio hit by trial failures, cash crunch

Data Compilation
#PharmaFlow

Pipeline Prospector 2024 highlights: Rise in new breed of biotechs with maiden approvals; GLP-1 meds show promise beyond obesity

Stock Recap
#PipelineProspector

Opatanol;Pataday;Patanase;Allelock

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

36 API Suppliers, 17 USDMF, 9 JDMF, 6 EU WC, 14 KDMF, 14 NDC API, 21 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

10 Drugs in Development

10 Drugs in Development

INTERMEDIATES

12 Intermediate Suppliers

12 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

85 FDF Dossiers, 35 FDA Orange Book, 13 Europe, 13 Canada, 2 South Africa, 22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION/DROPS;OPHTHALMIC - EQ 0.7% BASE, SOLUTION/DROPS;OPHTHALMIC - EQ 0.1% BASE, SOLUTION/DROPS;OPHTHALMIC - EQ 0.2% BASE, SPRAY, METERED;NASAL - 0.665MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 12 SPI Pharma, 1 DKSH, 2 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 5 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 1 Clariant, 10 Corel Pharma Chem, 1 Finar, 6 Gangwal Chemicals, 4 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 14 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 4 Microlex e.U, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 3 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material

EXCIPIENTS BY APPLICATIONS

40 Coating Systems & Additives, 31 Fillers, Diluents & Binders, 20 Controlled & Modified Release, 15 Direct Compression, 11 Taste Masking, 11 Chewable & Orodispersible Aids, 11 Parenteral, 10 Granulation, 10 Solubilizers, 8 Co-Processed Excipients, 7 Film Formers & Plasticizers, 5 Disintegrants & Superdisintegrants, 5 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Thickeners and Stabilizers, 3 Topical, 2 Coloring Agents, 2 Rheology Modifiers, 1 Surfactant & Foaming Agents, 1 Emulsifying Agents, 1 Lubricants & Glidants

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 48 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 12 Finished Drug Prices, 17 Annual Reports

MARKET PLACE

18 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

17 US Patents, 1 US Exclusivities, 6 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 3 Others

ANALYTICAL

3 Analytical Methods

3 Analytical Methods

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/01/2025	Seqens	France	PCAS	23908	OLOPATADINE HCL	2010-06-18	Active	II	Complete	2013-02-07	2013-01-02
28/01/2025	Medichem S.A	Spain	MEDICHEM SA	22532	MED-201345/E	2009-02-12	Active	II	Complete	2015-09-23	2015-09-14

Opatanol;Pataday;Patanase;Allelock

Opatanol;Pataday;Patanase;Allelock

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

36 API Suppliers

17 USDMF

9 JDMF

6 EU WC

14 KDMF

14 NDC API

21 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

10 Drugs in Development

INTERMEDIATES

12 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

85 FDF Dossiers

35 FDA Orange Book

13 Europe

13 Canada

2 South Africa

22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION/DROPS;OPHTHALMIC - EQ 0.7% BASE

SOLUTION/DROPS;OPHTHALMIC - EQ 0.1% BASE

SOLUTION/DROPS;OPHTHALMIC - EQ 0.2% BASE

SPRAY, METERED;NASAL - 0.665MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

12 SPI Pharma

1 DKSH

2 Faran Shimi Pharmaceutical

4 Boai NKY Pharmaceuticals Ltd

2 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

1 Pfanstiehl

1 ACG Worldwide

5 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

10 BASF

1 Clariant

10 Corel Pharma Chem

1 Finar

6 Gangwal Chemicals

4 Ideal Cures Pvt Ltd

1 Ingredion Pharma Solutions

14 Kerry

3 Kima Chemical

6 Lonza Capsugel

4 Microlex e.U

2 Novo Excipients

1 Pharmatrans-Sanaq

2 Pluviaendo

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

3 Roquette

6 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

2 The Dow Chemical Company

1 Ulanqab Kema New Material

EXCIPIENTS BY APPLICATIONS

40 Coating Systems & Additives

31 Fillers, Diluents & Binders

20 Controlled & Modified Release

15 Direct Compression

11 Taste Masking

11 Chewable & Orodispersible Aids

11 Parenteral

10 Granulation

10 Solubilizers

8 Co-Processed Excipients

7 Film Formers & Plasticizers

5 Disintegrants & Superdisintegrants

SPRAY, METERED;NASAL - 0.665MG/SPRAY Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons